LIVE MARKET TRACKER :   BSE SENSEX   27459.23      |    NSE NIFTY 8337.00    
GLOBAL MARKETS :  NASDAQ 5039.78   -0.96%    |    FSI London 6562.41   +0.88%    |    NIKKEI Japan 20328.89   -0.10%
  USD GBP EUR CAD AUD INR
USD - 0.6413 0.9066 1.3017 1.3680 63.9500
GBP 1.5593 - 1.4134 2.0302 2.1331 99.7484
EUR 1.1035 0.7080 - 1.4366 1.5094 70.5878
CAD 0.7684 0.4928 0.6966 - 1.0508 49.1548
AUD 0.7316 0.4692 0.6630 0.9522 - 46.7877
INR 0.0156 0.0100 0.0142 0.0204 0.0214 -
Indian-Commodity  :  Corporate  :  Ashoka Buildcon's toll collection rights withdrawn by Govt of Maharashtra

Ashoka Buildcon's toll collection rights withdrawn by Govt of Maharashtra (20-Nov-2012)

Ashoka Buildcon's toll collection rights for the project viz., 'Improvements to the Ahmednagar- Karmala Road State High Way No. 141 Km 0/0 To 80/600 Ahmednagar District Border under BOT Scheme (with toll rights), has been withdrawn by the PWD, Government of Maharashtra prematurely, which were to expire on November 04, 2015.

The notification from government states that the lending interest rates have been changed by the Reserve Bank of India and consequently as per contract provisions, the concession period in view of new lending rates reworked, has ended before November 14, 2012 and therefore considered it expedient to cease the effect and operation of the notification dated May 15, 2002 authorizing toll collection upto November 04, 2015. The company is proposing to take remedial action as permissible under law.

Ashoka Buildcon builds and operates roads and bridges in India on a build, operate and transfer (BOT) basis. It currently operates one of the highest numbers of toll-based BOT projects in India.


Top News Today
Glenmark Pharma, SAIL and Prestige Estate to see some action
(28-Jul-2015)

Glenmark Pharma, SAIL and Prestige Estate to see some actionThe US court ruled that India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent. The federal court......click on news to read complete article.

No need to fear any “knee-jerk” reaction on the SIT report: Arun Jaitley
(28-Jul-2015)

No need to fear any “knee-jerk” reaction on the SIT report: Arun JaitleyIn its bid to soothe the nerves of panic-stricken investors, Finance Minister Arun Jaitley has said they need not fear any “knee-jerk” reaction from the government on the SIT report, which had recommended......click on news to read complete article.

SIT recommends enacting tough laws to curb black money
(27-Jul-2015)

SIT recommends enacting tough laws to curb black moneyThe Supreme Court-appointed special investigation team (SIT) headed by Justice M B Shah (retd)  has recommended enacting tough laws to curb betting in cricket, bring donations to education and......click on news to read complete article.

International Stock News
US markets extend southward journey for fourth straight session
(25-Jul-2015)

US markets extend southward journey for fourth straight sessionExtending their southward journey for fourth straight session, US Markets ended the Friday's session with a cut of around a percentage point. Sentiments remained downbeat with report from the Commerce......click on news to read complete article.

US markets closed lower for third straight session
(24-Jul-2015)

US markets closed lower for third straight sessionThe US markets closed lower on Thursday, after the selling pressure accelerated in the afternoon session and the main indexes closed with losses for the third straight day, led lower by utilities, materials......click on news to read complete article.

US markets closed lower; Dow suffers triple-digit drop
(22-Jul-2015)

US markets closed lower; Dow suffers triple-digit dropThe US markets closed lower on Tuesday, with Dow posting triple-digit drop after IBM and United Technologies Corporation reported disappointing quarterly reports. IBM is the second highest-weighted component......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.